|
|
|
|
|
|
Sponsored by: |
Institute of Cancer Research, United Kingdom |
Information provided by: | National Cancer Institute (NCI) |
ClinicalTrials.gov Identifier: | NCT00107497 |
RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Giving radiation therapy in different ways and giving it after surgery may kill any tumor cells that remain after surgery.
PURPOSE: This randomized clinical trial is studying radiation therapy to see how well it works in treating women with localized breast cancer.
Condition | Intervention |
Breast Cancer |
Procedure: adjuvant therapy Procedure: radiation therapy |
Genetics Home Reference related topics: | breast cancer |
MedlinePlus related topics: | Breast Cancer Cancer |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Active Control |
Official Title: | Prospective Randomised Clinical Trial Testing 5.7 Gy and 6.0 Gy Fractions of Whole Breast Radiotherapy in Terms of Late Normal Tissue Responses and Tumour Control - FAST |
Estimated Enrollment: | 900 |
Study Start Date: | January 2005 |
OBJECTIVES:
OUTLINE: This is a randomized, multicenter study. Patients are stratified according to participating center. Patients are randomized to 1 of 3 treatment arms.
After completion of study treatment, patients are followed annually for 5-10 years.
PROJECTED ACCRUAL: A total of 900 patients (300 per treatment arm) will be accrued for this study within 12 months.
Ages Eligible for Study: | 50 Years and older |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
Diagnosis of invasive carcinoma of the breast
Localized disease
Must have undergone prior breast-preserving surgery
Hormone receptor status:
PATIENT CHARACTERISTICS:
Age
Sex
Menopausal status
Performance status
Life expectancy
Hematopoietic
Hepatic
Renal
Other
PRIOR CONCURRENT THERAPY:
Biologic therapy
Chemotherapy
Endocrine therapy
Radiotherapy
Surgery
United Kingdom | |||||
Halton Hospital - North Cheshire Hospitals NHS Trust | |||||
Cheshire, United Kingdom, WA7 2DA | |||||
Hereford Hospitals NHS Trust | |||||
Hereford, United Kingdom, HR1 2ER | |||||
United Kingdom, England | |||||
Berkshire Cancer Centre at Royal Berkshire Hospital | |||||
Reading, England, United Kingdom, RG1 5AN | |||||
Cheltenham General Hospital | |||||
Cheltenham, England, United Kingdom, GL53 7AN | |||||
Royal Cornwall Hospital | |||||
Truro, Cornwall, England, United Kingdom, TR1 3LJ | |||||
Clatterbridge Centre for Oncology NHS Trust | |||||
Merseyside, England, United Kingdom, CH63 4JY | |||||
Cumberland Infirmary | |||||
Carlisle, England, United Kingdom, CA2 7HY | |||||
Ipswich Hospital NHS Trust | |||||
Ipswich, England, United Kingdom, IP4 5PD | |||||
Christie Hospital NHS Trust | |||||
Manchester, England, United Kingdom, M20 4BX | |||||
Royal Devon and Exeter Hospital | |||||
Exeter, England, United Kingdom, EX2 5DW | |||||
Royal Marsden NHS Foundation Trust - Surrey | |||||
Sutton, England, United Kingdom, SM2 5PT | |||||
Royal Shrewsbury Hospital | |||||
Shrewsbury, England, United Kingdom, SY3 8XQ | |||||
Southend University Hospital NHS Foundation Trust | |||||
Westcliff-On-Sea, England, United Kingdom, SS0 0RY | |||||
Sussex Cancer Centre at Royal Sussex County Hospital | |||||
Brighton, England, United Kingdom, BN2 5BE | |||||
Torbay Hospital | |||||
Torquay Devon, England, United Kingdom, TQ2 7AA | |||||
University Hospital of North Staffordshire | |||||
Stoke-On-Trent, England, United Kingdom, ST4 7LN | |||||
Worcester Royal Hospital | |||||
Worcester, England, United Kingdom, WR5 1DD | |||||
Worthing Hospital | |||||
Worthing, England, United Kingdom, BN11 2DH | |||||
United Kingdom, Wales | |||||
Velindre Cancer Center at Velindre Hospital | |||||
Cardiff, Wales, United Kingdom, CF14 2TL |
Institute of Cancer Research, United Kingdom |
Study Chair: | John R. Yarnold, MD, FRCR | Royal Marsden - Surrey |
Clinical trial summary from the National Cancer Institute's PDQ® database 
  |
Study ID Numbers: | CDR0000417730, ICR-04/MRE06/17, ICR-FAST, ICR-FAST-04/MRE06/17, EU-20506 |
First Received: | April 5, 2005 |
Last Updated: | March 22, 2008 |
ClinicalTrials.gov Identifier: | NCT00107497 |
Health Authority: | United States: Federal Government |
|
|
|